Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
29 038 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32022R0692

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

xx xxx 16.&xxxx;xxxxx 2022,

xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku xxxx nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx

(Xxxx x&xxxx;xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x&xxxx;xxxxxxx xx Smlouvu x&xxxx;xxxxxxxxx Evropské unie,

s ohledem xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1272/2008 xx dne 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx látek x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (ES) x.&xxxx;1907/2006&xxxx;(1), x&xxxx;xxxxxxx na čl. 37 xxxx.&xxxx;5 xxxxxxxxx nařízení,

vzhledem x&xxxx;xxxxx důvodům:

(1)

Tabulka 3 x&xxxx;xxxxx 3 xxxxxxx XX nařízení (XX) x.&xxxx;1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxxxxx látek xx xxxxxxx xxxxxxxx stanovených x&xxxx;xxxxxxx 2 až 5 přílohy I uvedeného xxxxxxxx.

(2)

Xxxxxxxx xxxxxxxx pro xxxxxxxx xxxxx (xxxx xxx „xxxxxxxx“) xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (XX) x.&xxxx;1272/2008 předloženy xxxxxx na xxxxxxxx xxxxxxxxxxxxx klasifikace x&xxxx;xxxxxxxx xxxxxxxxx látek x&xxxx;xx xxxxxxxxxxx nebo xxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx xxxxxx xxxxx. Xxxx, xx Xxxxx xxx xxxxxxxxxx rizik (XXX) xxxxxxxx xxxxxxxxx xxxxxxxxxx zúčastněných stran, xxxxxx x&xxxx;xxxxx xxxxxxx xxxxxxxxxxx stanoviska (2):

—

stanovisko xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx křemičitým; xxxxxxxxx xxxxxxxxxx amorfní xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx úpravou,

—

stanovisko xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxx (ISO), [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx β-cyfluthrin (XXX); xxxxxxx xxxx: rel-(R)-kyan(4-fluor-3-fenoxyfenyl)methyl-(1S,3S)-3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropan-1-karboxylát x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1S,3R)-3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropan-1-karboxylát,

—

stanovisko xx xxx 4.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxxx (XXX); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-chlor-3-pyridyl)methyl]-N 2-kyan-N 1-xxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx oxid xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx tribromderivát 2,2-dimethylpropan-1-olu; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx piperonylbutoxid (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx kyselinu,

—

stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx,

—

xxxxxxxxxx xx dne 11. června 2020 xxx fluopikolid (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—

xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx posouzení xxxxxxxx xxxxxxxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxxx xxxx xx xxxxxx Xxxxxxxx komise,

—

stanovisko ze xxx 17.&xxxx;xxxx&xxxx;2020 pro xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxx xxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx chinoklamin (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx 4,4’-oxydi(benzensulfonohydrazid),

—

stanovisko xx xxx 17. září 2020 xxx toluen-4-sulfonohydrazid,

—

stanovisko xx xxx 17. září 2020 xxx xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX],

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI],

—

stanovisko ze xxx 17. září 2020 xxx 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx triamid xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 pro xxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; trimethylolpropan-triakrylát,

—

stanovisko xx xxx 17. září 2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující < 0,1 % xxxx. xxxxxx s aerodynamickým xxxxxxxx menším než 50 μx],

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující ≥&xxxx;0,1&xxxx;% xxxx. xxxxxx s aerodynamickým xxxxxxxx menším xxx 50 μm],

—

stanovisko xx xxx 8. října 2020 xxx xxxxxx amonný,

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 2,4,6-xxx-xxxx-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx pyridalyl (XXX); 2,6-dichlor-4-(3,3-dichlorallyloxy)fenyl{3-[5-(trifluormethyl)-2-pyridyloxy]propyl}ether,

—

stanovisko xx xxx 8. října 2020 xxx xxxxxxx-2-xxxxx-1-xxxx, xxxxxx xxx; xxxxxx xxx xxxxxxxxxx; xxxxxxxxx xxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; isoflucypram,

—

stanovisko ze xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 4,4′-xxxxxxxxxxxxxxxxxxxx; bisfenol A,

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxxxxxxxx (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx ze dne 10.&xxxx;xxxxxxxx&xxxx;2020 pro 2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Xxxx 124,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxxx xxxxxxxxxxxxxxxxxx; xxxxxxxx xxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxx xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 10. prosince 2020 xxx 6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx, sodné x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx,

—

xxxxxxxxxx ze xxx 10. prosince 2020 xxx 6-[xxxxx-(X10-X13, rozvětvené, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx dne 10. prosince 2020 xxx 1,3,5-xxxxxxx-2,4,6-xxxxxxx; melamin,

—

stanovisko xx xxx 10. prosince 2020 xxx xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [relativní xxxxx ≥&xxxx;78&xxxx;% syn-isomerů x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], isopyrazam,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx margosy, extraktu [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx, xxxxxxxxxxx xxxxx x&xxxx;xxxx zpracovaný xxxxxxxxxxx xxxxxxxxxxxx],

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx xxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx bentazon (XXX), 3-xxxxxxxxx-2,1,3-xxxxxxxxxxxxxxx-4-xx-2,2-xxxxxx,

—

xxxxxxxxxx ze xxx 10. prosince 2020 ohledně xxxxxxxxxx posouzení xxxxxx xxxxxxxxx x&xxxx;xxxxxx inhalační xxxxxxxx 2-xxxxxxxxxxx-1-xxx; ethylenglykol-monobutyl-etheru (XXXX) xx xxxxxx Xxxxxxxx xxxxxx.

(3)

Xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx, které xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxx ve stanoviscích XXX xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-ethylhexanovou xxxxxxxx a její soli; xx dne 11. června 2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxx toxicity {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxx pentasodných x&xxxx;xxxxxxxxxxxxxxx xxxx xx xxxxxx Xxxxxxxx xxxxxx, xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx bromid amonný, xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx vanadičný, xx dne 10. prosince 2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxx informací x&xxxx;xxxxxx xxxxxxxxx toxicitě 2-butoxyethan-1-olu; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) na xxxxxx Evropské xxxxxx x&xxxx;xx xxx 10. prosince 2020 xxx xxxxxxx.

(4)

Xxxxxx xxxx xxxxxxxxx informace xxxxxxxxx x&xxxx;xxxxxxxxxx xx za xxxxxxxxxx k tomu, xxx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx xx stanoviscích XXX. Xx xxxxxxx xxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx xx xxxxx xxxxxx xxxxxx, xxxxxxxxxxxx xxxx xxxxxx harmonizovanou xxxxxxxxxxx x&xxxx;xxxxxxxx dotčených xxxxx.

(5)

Xxxx, xx xxxx Xxxxxx xxxxxxx xxxxxxxxxx XXX, xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxxxx xx akutní xxxxxxxxx xxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx hydrolýzy x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx. Xxxxxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx hydrolýzy s oxidem xxxxxxxxxx; xxxxxxxxxxx syntetického xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxx kategorie 2, xxxxxxxxxx ve stanovisku XXX xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019, xx xxxxxx xxx zařazena do xxxxxxx XX nařízení (XX) č. 1272/2008, neboť Xxxxxx nové xxxxxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx, xx by bylo xxxxx xxxxx xxxxxxxxx XXX. Xx xxxxxxx XX nařízení (XX) x.&xxxx;1272/2008 xx však xxxx xxx xxxxxxxx xxxxxxxxxxx xxxx látky xxxx XXXX RE 2, xxxxxxxxxx xx xxxxxxxxxx výboru XXX xx dne 5. prosince 2019, xxxxx xxxxxx xxxxxxxx xxxxx xxxx xxxxxxxxx, xxxxx xx xxxxxxxxxx xxxxx xxxxxxxxx xxxx xxxxxxxxxxx.

(6)

Xxxxxxxx (ES) x.&xxxx;1272/2008 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx xxxx xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xx xxxxxx xxx xxxxxxxxxx ihned, xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx xxxx xx to, xxx xxxxxxxxxxxx označování x&xxxx;xxxxxx xxxxx a směsí xxxxx xxxx aktualizovaným xxxxxxxxxxxx a prodali xxxxxxxxx xxxxxx, xx které xx vztahují předchozí xxxxxxxxxxx xxxxxxxxx. Tato xxxx je xxxxxx xxxxxxxx k tomu, xxx xxxxxxxxxx měli xxxxxxxx xxxx přijmout opatření xxxxx x&xxxx;xxxxxxxxx xxxxxxxx xxxxxxxxxx dalších xxxxxxxx xxxxxxxxx, xxxxx xxxxxxxx x&xxxx;xxxxxxxx změn provedených xxxxx xxxxxx nařízení. Xxxxxxxxxxx xx xxxx xxxx xxx umožněno xxxxxxxx nové xxxx xxxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx na xxxxxxxxxxx základě xxxx xxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxx, aby xxxx xxxxxxxxx xxxxxx úroveň xxxxxxx lidského zdraví x&xxxx;xxxxxxxxx prostředí x&xxxx;xxx xx dodavatelům xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Xxxxxxx VI nařízení (XX) x.&xxxx;1272/2008 xx xxxx v souladu s přílohou xxxxxx nařízení.

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxx

Xxxx xxxxxxxx xxxxxxxx v platnost xxxxxxxx dnem po xxxxxxxxx v Úředním věstníku Xxxxxxxx xxxx.

Xxxxxxx xx xxx xxx 23.&xxxx;xxxxxxxxx 2023.

Xxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx xxxxxx xxxxx být xxxxx x&xxxx;xxxxx klasifikovány, označovány x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxx xxxxxxxxx xxx xxx xxxx xxxxxx v platnost.

Xxxx xxxxxxxx xx xxxxxxx v celém rozsahu x&xxxx;xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx státech.

V Bruselu xxx 16.&xxxx;xxxxx 2022.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx VON DER XXXXX

(1)&xxxx;&xxxx;Xx. věst. L 353, 31.12.2008, s. 1.

(2)  Stanoviska xxxx xxxxxxxx na xxxx xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/. – Xxxxxxxxxx xx xxx 11. června 2020 x&xxxx;xx xxx 10. prosince 2020 xxxxxxxx xx opětovného posouzení xx xxxxxx Xxxxxxxx xxxxxx xxxx k dispozici xx xxxx internetové xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxx-xx/xxx-xx-xxx/xxxxxxxxx-xxx-xxxx-xxxxxxxxxx/xxxxxxxx-xx-xxx-xxx-xxxxxxx-xxxxx-xxxxxxxx-xxxx-x-xxxxxxxxx-xxxxxxxx-xxxxxxxx

PŘÍLOHA

Příloha XX xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx xxxxx:

1)

x&xxxx;xxxxx 3 xx tabulka 3 xxxx takto:

a)

vkládají xx xxxx xxxxxxx:

Xxxxxxxx číslo

Chemický xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx a signálních slov

Kódy xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„014-052-00-7

xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, produkty xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx úpravou

272-697-1

68909-20-6

STOT RE 2

X373 (xxxxx) (xxxxxxxxxx)

XXX08

Xxx

X373 (xxxxx) (vdechování)

EUH066“

„035-005-00-7

bromid xxxxxx

235-183-8

12124-97-9

Xxxx. 1X

Xxxx.

XXXX XX 3

XXXX XX 1

Xxx Irrit. 2

X360XX

X362

X336

X372 (nervový xxxxxx)

X319

XXX08

XXX07

Xxx

X360XX

X362

X336

X372 (xxxxxxx systém)

H319“

„050-032-00-4

dibutylcín-bis(2-ethylhexanoát)

220-481-2

2781-10-4

Muta. 2

Xxxx. 1X

XXXX XX 1

X341

X360XX

X372 (xxxxxxxx systém)

GHS08

Dgr

H341

H360FD

H372 (xxxxxxxx xxxxxx)“

„050-033-00-X

xxxxxxxxxx-xxxxxxxx

213-928-8

1067-33-0

Xxxx. 2

Xxxx. 1B

STOT XX 1

X341

X360XX

X372 (imunitní xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„052-001-00-0

xxxxxx

236-813-4

13494-80-9

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„052-002-00-6

xxxx telluričitý

231-193-1

7446-07-3

Repr. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„056-005-00-3

xxxxxxxxx xxxxxxx-xxxxxxxx

237-222-4

13701-59-2

Xxxx. 1B

Acute Xxx. 4

Xxxxx Tox. 3

X360XX

X332

X301

XXX08

XXX06

Xxx

X360XX

X332

X301

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 100 mg/kg XX“

„601-097-00-8

xxxxxxxxxxxx

203-132-9

103-65-1

Xxxx. Xxx. 3

Xxx. Tox. 1

XXXX XX 3

Xxxxxxx Xxxxxxx 2

H226

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H304

H335

H411“

„603-243-00-6

tribromderivát 2,2-dimethylpropan-1-olu; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx

253-057-0

36483-57-5; 1522-92-5

Xxxx. 1B

Muta. 2

X350

X341

XXX08

Xxx

X350

X341“

„604-096-00-0

xxxxxxxxxxxxxxxx (ISO); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx

200-076-7

51-03-6

XXXX XX 3

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X335

X319

X400

X410

XXX07

XXX09

Xxx

X335

X319

X410

XXX066

X&xxxx;= 1

X&xxxx;= 1“

„604-097-00-6

2,4,6-xxx-xxxx-xxxxxxxxxx

211-989-5

732-26-3

Xxxx. 1B

Acute Tox. 4

XXXX XX 2

Xxxx Xxxx. 1X

X360X

X302

X373 (játra)

H317

GHS08

GHS07

Dgr

H360D

H302

H373 (xxxxx)

X317

xxxxxx:

XXX&xxxx;= 500 mg/kg XX“

„604-098-00-1

4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X

201-250-5

80-09-1

Xxxx. 1B

H360FD

GHS08

Dgr

H360FD“

„606-153-00-5

benzofenon

204-337-6

119-61-9

Carc. 1X

X350

XXX08

Xxx

X350“

„606-154-00-0

xxxxxxxxxxx (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx

220-529-2

2797-51-5

Xxxx. 2

Xxxx. 2

Acute Tox. 4

XXXX XX 2

Xxx Xxxxx. 2

Skin Xxxx. 1&xxxx;X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H302

H373 (xxxxxx xxxx, xxxxxxx)

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X361x

X302

X373 (krevní xxxx, xxxxxxx)

X319

X317

X410

xxxxxx:

XXX&xxxx;= 500 mg/kg XX

X&xxxx;= 10

X&xxxx;= 10“

„607-756-00-6

exo-1,7,7-trimethylbicyklo[2.2.1]hept-2-yl-akrylát; xxxxxxxxx-xxxxxxx

227-561-6

5888-33-5

Xxxx Xxxx. 1&xxxx;X

X317

XXX07

Xxx

X317“

„607-757-00-1

xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxx kyselina; X-(xxxxxxxxxxxxx)xxxxxxxxxxx kyselina

216-485-9

1596-84-5

Carc. 2

H351

GHS08

Wng

H351“

„607-758-00-7

4,4′-oxydi(benzensulfonohydrazid)

201-286-1

80-51-3

Self-react. X

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

H242

H400

H410

GHS02

GHS09

Dgr

H242

H410

M = 1

X&xxxx;= 1“

„607-759-00-2

xxxxxx-4-xxxxxxxxxxxxxxx

216-407-3

1576-35-8

Xxxx-xxxxx. X

X242

XXX02

Xxx

X242“

„607-760-00-8

2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Xxxx 124

239-203-6

15141-18-1

Skin Xxxx. 1 A

H317

GHS07

Wng

H317

Skin Xxxx. 1&xxxx;X; H317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„607-761-00-3

xxxxxxxxxxxxxxxxx xxxxxxxx; tridekafluorheptanová kyselina

206-798-9

375-85-9

Repr. 1X

XXXX RE 1

X360X

X372 (xxxxx)

XXX08

Xxx

X360X

X372 (játra)“

„607-762-00-9

methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; valifenalát

-

283159-90-0

Carc. 2

Xxxxxxx Chronic 2

H351

H411

GHS08

GHS09

Wng

H351

H411“

„607-763-00-4

6-[alkyl-(C12-C18, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanová xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx soli

-

-

Repr. 1X

Xxx Irrit. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319“

„607-764-00-X

6-[alkyl-(C10-C13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx kyselina

-

2156592-54-8

Repr. 1X

Xxx Irrit. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319“

„607-765-00-5

6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx

-

-

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX“

„613-341-00-0

xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx

277-728-2

74115-24-5

Xxxxxxx Xxxxxxx 1

X410

XXX09

Xxx

X410

X&xxxx;= 1“

„613-342-00-6

xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx

200-385-7

58-55-9

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„613-343-00-1

xxxxxxxxx (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx

-

179101-81-6

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1 000

M = 100“

„613-344-00-7

xxxxxxx-2-xxxxx-1-xxxx, xxxxx xxx; xxxxx xxx xxxxxxxxxx; xxxxxxxxx xxxxx

223-296-5;

240-062-8

3811-73-2;

15922-78-8

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Xxxxx Xxx. 4

XXXX XX 1

Xxxx Xxxxx. 2

Eye Irrit. 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 2

X331

X311

X302

X372 (nervový xxxxxx)

X315

X319

X317

X400

X411

XXX06

XXX08

XXX09

Xxx

X331

X311

X302

X372 (xxxxxxx xxxxxx)

X315

X319

X317

X410

XXX070

xxxxxxxxx:

XXX&xxxx;= 0,5&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxxxx:

XXX&xxxx;= 790&xxxx;xx/xx XX

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 100“

„613-345-00-2

1,3,5-xxxxxxx-2,4,6-xxxxxxx;

xxxxxxx

203-615-4

108-78-1

Xxxx. 2

STOT XX 2

X351

X373 (xxxxxx xxxxx)

XXX08

Xxx

X351

X373 (xxxxxx xxxxx)“

„615-046-00-2

1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX]

220-474-4

2778-42-9

Xxxx. Xxxx. 1

Xxxx Xxxx. 1 A

H334

H317

GHS08

Dgr

H334

H317“

„615-047-00-8

1,3-bis(isokyanatomethyl)benzen; [m-XDI]

222-852-4

3634-83-1

Resp. Xxxx. 1

Skin Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317

Xxxx Sens. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„615-048-00-3

2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx

218-485-4

2162-73-4

Xxxx. Xxxx. 1

Xxxx Xxxx. 1

X334

X317

XXX08

Xxx

X334

X317“

„615-049-00-9

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μx]

221-641-4

3173-72-6

XXXX XX 3

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Resp. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

Xxxxxxx Chronic 3

X335

X315

X319

X334

X317

X412

XXX07

XXX08

Xxx

X335

X315

X319

X334

X317

X412“

„615-050-00-4

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μx]

221-641-4

3173-72-6

Xxxxx Xxx. 2

XXXX XX 3

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Resp. Sens. 1

Xxxx Sens. 1 A

Aquatic Xxxxxxx 3

X330

X335

X315

X319

X334

X317

X412

XXX06

XXX08

Xxx

X330

X335

X315

X319

X334

X317

X412

xxxxxxxxx:

XXX&xxxx;= 0,27&xxxx;xx/x (xxxxx nebo xxxx)“

„616-237-00-3

xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx

-

239110-15-7

Xxxx. 2

H361d

GHS08

Wng

H361d“

„616-238-00-9

triamid xxxxxxxx N-(2-nitrofenyl)fosforečné

477-690-9

874819-71-3

Repr. 1X

XXXX XX 2

X360Xx

X373 (xxxxxxx)

XXX08

Xxx

X360Xx

X373 (xxxxxxx)“

„616-239-00-4

X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx

-

1255734-28-1

Xxxx. 2

Xxxxx Xxx. 4

Xxxx Xxxx. 1X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X332

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X361x

X332

X317

X410

xxxxxxxxx:

XXX&xxxx;= 2,2 mg/l (xxxxx xxxx mlha)

M = 10

X&xxxx;= 1“

„616-240-00-X

xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx

-

881685-58-1

Xxxx. 2

Xxxx. 1X

Xxxx Xxxx. 1X

Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1

H351

H360D

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H317

H410

Repr. 1X; H360D:

C ≥ 3 %

M = 10

M = 10“

„650-058-00-1

Xxxxxxx, xxxxxxx [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx indica, xxxxxxxxxxx xxxxx a dále xxxxxxxxxx xxxxxxxxxxx rozpouštědly]

283-644-7

84696-25-3

Repr. 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxxxx 1

H361d

H317

H410

GHS08

GHS07

GHS09

Wng

H361d

H317

H410

M = 10“

x)

xxxxxxx xxxxxxxxxxxx indexovým xxxxxx 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 xx xxxxxxxxx těmito xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx symbolů x&xxxx;xxxxxxxxxx xxxx

Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. standardních xxx x&xxxx;xxxxxxxxxxxxx

„014-001-00-9

xxxxxxxxxxxxx

233-042-5

10025-78-2

Xxxx. Liq. 1

Xxxxx-xxxxx. 1

Xxxxx Tox. 3

Xxxxx Tox. 4

Skin Xxxx. 1&xxxx;X

Xxx Xxx. 1

X224

X260

X331

X302

X314

X318

XXX02

XXX06

XXX05

Xxx

X224

X260

X331

X302

X314

XXX014

XXX029

XXX071

xxxxxxxxx:

XXX&xxxx;= 7,6 mg/l (páry)

orální:

ATE = 1&xxxx;000  mg/kg XX“

„023-001-00-8

xxxx xxxxxxxxx

215-239-8

1314-62-1

Xxxx. 2

Xxxx. 1B

Repr. 2

Xxxx.

Xxxxx Tox. 3

Acute Xxx. 2

XXXX XX 3

XXXX RE 1

Xxxxxxx Xxxxxxx 2

H341

H350

H361fd

H362

H301

H330

H335

H372 (xxxxxxx xxxxx, xxxxxxxxxx)

X411

XXX06

XXX08

XXX09

Xxx

X341

X350

X361xx

X362

X301

X330

X335

X372 (dýchací xxxxx, xxxxxxxxxx)

X411

xxxxxxxxx:

XXX&xxxx;= 0,05&xxxx;xx/x (xxxxx nebo mlha)

orální:

ATE = 220&xxxx;xx/xx TH“

„601-024-00-X

kumen

202-704-5

98-82-8

Flam. Xxx. 3

Xxxx. 1B

Asp. Xxx. 1

XXXX XX 3

Aquatic Xxxxxxx 2

H226

H350

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H350

H304

H335

H411“

„603-014-00-0

2-butoxyethan-1-ol; xxxxxxxxxxxxx-xxxxxxxxx-xxxxx

203-905-0

111-76-2

Xxxxx Xxx. 3

Acute Tox. 4

Xxxx Irrit. 2

Xxx Xxxxx. 2

X331

X302

X315

X319

XXX06

Xxx

X331

X302

X315

X319

xxxxxxxxx:

XXX&xxxx;= 3&xxxx;xx/x (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;200 &xxxx;xx/xx XX“

„603-107-00-6

2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

203-906-6

111-77-3

Xxxx. 1B

H360D

GHS08

Dgr

H360D

Repr. 1X; H360D: X&xxxx;≥&xxxx;3&xxxx;%“

„604-030-00-0

4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx A

201-245-8

80-05-7

Repr. 1X

XXXX XX 3

Xxx Xxx. 1

Xxxx Sens. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X360X

X335

X318

X317

X400

X410

XXX08

XXX07

XXX05

XXX09

Xxx

X360X

X335

X318

X317

X410

X&xxxx;= 1

X&xxxx;= 10“

„607-111-00-9

2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx;

xxxxxxxxxxxxxxxxx-xxxxxxxxxx

239-701-3

15625-89-5

Xxxx. 2

Xxxx Irrit. 2

Xxx Xxxxx. 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X315

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X315

X319

X317

X410

X&xxxx;= 1

X&xxxx;= 1

D“

„607-230-00-6

2-ethylhexanová xxxxxxxx x&xxxx;xxxx xxxx, s výjimkou xxxx, které xxxx xxxxxxx xxxxx v této xxxxxxx

-

-

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„607-253-00-1

xxxxxxxxxx (XXX); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

269-855-7

68359-37-5

Xxxx.

Xxxxx Xxx. 2

Acute Xxx. 2

XXXX SE 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X362

X330

X300

X370 (nervový xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,14&xxxx;xx/x (prach nebo xxxx)

xxxxxx:

XXX&xxxx;= 14&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1 000 000 “

„607-254-00-7

β-cyfluthrin (XXX); reakční xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

-

1820573-27-0

Xxxx.

Xxxxx Tox. 2

Xxxxx Xxx. 2

STOT XX 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,081&xxxx;xx/x (xxxxx xxxx mlha)

orální:

ATE = 11 mg/kg XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1&xxxx;000&xxxx;000 “

„607-734-00-6

xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(xxxxx-1,2-xxxxxxxxxxx)xxxxxxxxxxx

404-290-3

7216-95-7

Xxxx. 1X

Xxxxx Xxx. 4

XXXX XX 2

Xxx Irrit. 2

X360X

X332

X373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1B; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx mlha)“

„607-735-00-1

{[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctová xxxxxxxx

200-652-8

67-43-6

Xxxx. 1B

Acute Xxx. 4

XXXX XX 2

Xxx Xxxxx. 2

X360X

X332

X373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-736-00-7

xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]

205-391-3

140-01-2

Xxxx. 1X

Xxxxx Xxx. 4

STOT RE 2

X360X

X332

X373 (xxxxxxxxxx)

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

Xxxx. 1X; X360X: C ≥ 3 %

inhalační:

ATE = 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„608-032-00-2

xxxxxxxxxxx (XXX); (1E)-N-[(6-chlorpyridin-3-yl)methyl]-N’-kyan-N-methylethanimidamid; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx

-

135410-20-7&xxxx;160430-64-8

Xxxx. 2

Xxxxx Tox. 3

Xxxxxxx Chronic 1

Aquatic Xxxxx 1

X361x

X301

X410

X400

XXX08

XXX06

XXX09

Xxx

X361x

X301

X410

xxxxxx:

XXX&xxxx;= 140&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„609-042-00-X

xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx

254-938-2

40487-42-1

Xxxx. 2

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 100

X&xxxx;= 10“

„613-012-00-1

xxxxxxxx (XXX); 3-xxxxxxxxx-1X-2,1,3-xxxxxxxxxxxxxxx-4(3X)-xx-2,2-xxxxxx

246-585-8

25057-89-0

Xxxx. 2

Xxxxx Xxx. 4

Xxx Xxxxx. 2

Xxxx Sens. 1

H361d

H302

H319

H317

GHS08

GHS07

Wng

H361d

H302

H319

H317

orální: XXX&xxxx;= 1&xxxx;600  mg/kg XX“

„616-164-00-7

xxxxxxxxxxxxx (XXX); (2E)-2-{2-[(2,5-dimethylfenoxy)methyl]fenyl}-2-(methoxyimino)-N-methylacetamid; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

Xxxx. 2

Xxxx. 2

Acute Xxx. 4

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X351

X361x

X332

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X361x

X332

X410

xxxxxxxxx:

XXX&xxxx;= 1,3&xxxx;xx/x (prach xxxx xxxx)

X&xxxx;= 100

X&xxxx;= 100“

c)

položka xxxxxxxxxxxx indexovému xxxxx 615-007-00-X xx xxxxxxx.